337 related articles for article (PubMed ID: 24882721)
21. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Foust KD; Nurre E; Montgomery CL; Hernandez A; Chan CM; Kaspar BK
Nat Biotechnol; 2009 Jan; 27(1):59-65. PubMed ID: 19098898
[TBL] [Abstract][Full Text] [Related]
22. Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes.
Harrop JS; Poulsen DJ; Xiao W; Freese A; During MJ
Spine (Phila Pa 1976); 2004 Dec; 29(24):2787-92. PubMed ID: 15599280
[TBL] [Abstract][Full Text] [Related]
23. Targeting adenoviral transgene expression to neurons.
Sims K; Ahmed Z; Gonzalez AM; Read ML; Cooper-Charles L; Berry M; Logan A
Mol Cell Neurosci; 2008 Nov; 39(3):411-7. PubMed ID: 18722531
[TBL] [Abstract][Full Text] [Related]
24. Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression.
Lonergan T; Teschemacher AG; Hwang DY; Kim KS; Pickering AE; Kasparov S
Physiol Genomics; 2005 Jan; 20(2):165-72. PubMed ID: 15561757
[TBL] [Abstract][Full Text] [Related]
25. Gene expression along the cerebral-spinal axis after regional gene delivery.
Meuli-Simmen C; Liu Y; Yeo TT; Liggitt D; Tu G; Yang T; Meuli M; Knauer S; Heath TD; Longo FM; Debs RJ
Hum Gene Ther; 1999 Nov; 10(16):2689-700. PubMed ID: 10566897
[TBL] [Abstract][Full Text] [Related]
26. Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters.
Hioki H; Kameda H; Nakamura H; Okunomiya T; Ohira K; Nakamura K; Kuroda M; Furuta T; Kaneko T
Gene Ther; 2007 Jun; 14(11):872-82. PubMed ID: 17361216
[TBL] [Abstract][Full Text] [Related]
27. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.
Klein RL; Meyer EM; Peel AL; Zolotukhin S; Meyers C; Muzyczka N; King MA
Exp Neurol; 1998 Apr; 150(2):183-94. PubMed ID: 9527887
[TBL] [Abstract][Full Text] [Related]
28. pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.
Montesinos MS; Chen Z; Young SM
J Neurophysiol; 2011 Dec; 106(6):3230-44. PubMed ID: 21957229
[TBL] [Abstract][Full Text] [Related]
29. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
[TBL] [Abstract][Full Text] [Related]
30. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
[TBL] [Abstract][Full Text] [Related]
31. Recombinant AAV-mediated gene delivery to the central nervous system.
Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
[TBL] [Abstract][Full Text] [Related]
32. Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6.
Towne C; Schneider BL; Kieran D; Redmond DE; Aebischer P
Gene Ther; 2010 Jan; 17(1):141-6. PubMed ID: 19727139
[TBL] [Abstract][Full Text] [Related]
33. Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina.
Joussemet B; Belbellaa B; Mendes-Madeira A; Bucher T; Briot-Nivard D; Dubreil L; Colle MA; Cherel Y; Moullier P; Rolling F
Exp Eye Res; 2011 Oct; 93(4):491-502. PubMed ID: 21723863
[TBL] [Abstract][Full Text] [Related]
34. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
[TBL] [Abstract][Full Text] [Related]
35. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease.
Bucher T; Colle MA; Wakeling E; Dubreil L; Fyfe J; Briot-Nivard D; Maquigneau M; Raoul S; Cherel Y; Astord S; Duque S; Marais T; Voit T; Moullier P; Barkats M; Joussemet B
Hum Gene Ther; 2013 Jul; 24(7):670-82. PubMed ID: 23799774
[TBL] [Abstract][Full Text] [Related]
36. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.
Federici T; Taub JS; Baum GR; Gray SJ; Grieger JC; Matthews KA; Handy CR; Passini MA; Samulski RJ; Boulis NM
Gene Ther; 2012 Aug; 19(8):852-9. PubMed ID: 21918551
[TBL] [Abstract][Full Text] [Related]
37. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters.
Peel AL; Zolotukhin S; Schrimsher GW; Muzyczka N; Reier PJ
Gene Ther; 1997 Jan; 4(1):16-24. PubMed ID: 9068791
[TBL] [Abstract][Full Text] [Related]
38. AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease.
Xue YQ; Ma BF; Zhao LR; Tatom JB; Li B; Jiang LX; Klein RL; Duan WM
Gene Ther; 2010 Jan; 17(1):83-94. PubMed ID: 19727138
[TBL] [Abstract][Full Text] [Related]
39. Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9.
Van der Perren A; Toelen J; Carlon M; Van den Haute C; Coun F; Heeman B; Reumers V; Vandenberghe LH; Wilson JM; Debyser Z; Baekelandt V
Gene Ther; 2011 May; 18(5):517-27. PubMed ID: 21326331
[TBL] [Abstract][Full Text] [Related]
40. [Monitoring retrograde adenoviral transgene expression in spinal cord and anterograde labeling of the peripheral nerves].
Han J; Zhang Y; Chen W; Song C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):215-20. PubMed ID: 15828479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
